According to a 2025 Kaiser Family Foundation poll, one in eight adults in the U.S. are currently taking a GLP-1 medication. This number has probably increased even more since the poll was conducted, ...

A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again.

Glucagon-like peptide-1 receptor agonists (GLP-1s) are a class of medication that includes Ozempic®, Wegovy®, and Saxenda®. Some GLP-1s are diabetes drugs, but you can also take a GLP-1 for weight ...

If you miss a dose of GLP-1, you may be able to take it right away or wait until your next scheduled dose. It depends on the medication you take and how many doses you’ve missed. Glucagon-like peptide ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In recent years, GLP-1 peptides have become an increasingly ...

A combination of resistance and cardio exercise has benefits for most people, but especially for people taking a GLP-1. It can help preserve muscle and bone density, improve heart and lung health, and ...

New real-world evidence suggests that staying on GLP-1 therapy may be critical for sustaining cardiovascular protection, while even short interruptions could diminish long-term benefits in people with ...